| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 686.63M | 545.53M | 463.41M | 380.92M | 218.34M |
| Gross Profit | 268.77M | 215.62M | 178.26M | 145.99M | 57.14M |
| EBITDA | -37.50M | -28.20M | -52.30M | -66.77M | -56.93M |
| Net Income | -61.75M | -50.40M | -67.47M | -79.06M | -61.38M |
Balance Sheet | |||||
| Total Assets | 703.72M | 680.13M | 707.39M | 734.11M | 502.59M |
| Cash, Cash Equivalents and Short-Term Investments | 219.14M | 239.84M | 268.78M | 319.43M | 116.73M |
| Total Debt | 349.26M | 295.14M | 299.52M | 302.32M | 22.47M |
| Total Liabilities | 426.98M | 364.53M | 376.97M | 362.31M | 77.10M |
| Stockholders Equity | 275.60M | 314.45M | 329.30M | 370.71M | 424.45M |
Cash Flow | |||||
| Free Cash Flow | -24.09M | -33.48M | -48.36M | -76.22M | -74.83M |
| Operating Cash Flow | 6.09M | -15.38M | -29.88M | -62.58M | -68.57M |
| Investing Cash Flow | -16.64M | -20.18M | 16.81M | 15.14M | -212.75M |
| Financing Cash Flow | 2.89M | 4.64M | 1.07M | 280.97M | 307.77M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $17.12B | 33.14 | 17.85% | 0.79% | 8.01% | 2.67% | |
76 Outperform | $11.22B | 44.65 | 13.56% | ― | 12.60% | 24.02% | |
73 Outperform | $11.14B | 33.49 | 16.49% | 1.17% | 3.19% | 69.89% | |
68 Neutral | $16.02B | 25.11 | 17.48% | 0.96% | 0.83% | -1.32% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | $13.52B | 85.73 | 6.22% | ― | 5.52% | 9.03% | |
47 Neutral | $2.15B | -34.50 | -20.93% | ― | 22.40% | -18.99% |
Xometry announced on February 24, 2026, that its board approved a leadership transition effective July 1, 2026, elevating President Sanjeev Singh Sahni to chief executive officer and adding him to the board as a Class I director, while expanding the board from six to seven members to accommodate his appointment. The company also detailed that current CEO Randolph Altschuler will step down from that role on July 1, 2026, to become executive chair for an indefinite term, and that current board chair Fabio Rosati will shift to lead independent director, moves that collectively reshape governance while keeping key leaders in influential positions.
These changes signal a planned succession that preserves continuity in Xometry’s strategic direction by retaining Altschuler as executive chair and promoting an internal leader to CEO. The revised board structure, including the enlarged board and a defined lead independent director role, may strengthen oversight and balance executive influence, with implications for investors focused on governance stability and long-term execution.
The most recent analyst rating on (XMTR) stock is a Hold with a $64.00 price target. To see the full list of analyst forecasts on Xometry stock, see the XMTR Stock Forecast page.